← Back to the referencePrint this page (⌘P / Ctrl-P) and choose Save as PDF.
Peptide dosing reference
RES Institute · 122 entries across 19 categories · compiled 2026-09-29 · source: peptideprotocolportal.com
Reported, not recommended.
This table records what the published literature and reference material state. It is not a protocol, not a recommendation, and not medical advice. Nothing here establishes that any figure is safe, effective or appropriate for anyone, and no row should be read as an instruction to act on.
Everything referenced is supplied for professional research use only and is not for human or animal consumption. If you are considering any of this in a person, that is a conversation with a licensed clinician who knows your history — not a decision to take from a table.
Healing & Repair
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| BPC-157 | 5mg | 250-750mcg | Daily | SubQ/IM | Can inject locally near injury. Works synergistically with TB-500 |
| BPC-157 | 10mg | 250-750mcg | Daily | SubQ/IM | Can inject locally near injury. Works synergistically with TB-500 |
| TB-500 (Thymosin Beta-4) | 5mg | 2.5-5mg | 2x/week | SubQ | Works synergistically with BPC-157 |
| TB-500 (Thymosin Beta-4) | 10mg | 2.5-5mg | 2x/week | SubQ | Works synergistically with BPC-157 |
| BPC-157/TB-500 Blend (Wolverine) | 5mg/5mg | 500mcg-2mg | 5-7 days/week | SubQ/IM | DO NOT inject near injury site |
| BPC-157/TB-500 Blend (Wolverine) | 10mg/10mg | 500mcg-2mg | 5-7 days/week | SubQ/IM | DO NOT inject near injury site |
| AHK-Cu | 5mg | 200-500mcg | 5 days on / 2 off | SubQ | Copper peptide. Wound healing, hair growth, skin rejuvenation. Enhanced tissue targeting vs. GHK-Cu |
| GLOW Blend (GHK-Cu / BPC-157 / TB-500) | 70mg | 3.5-7mg | Daily x 20 days | SubQ | Skin, longevity, healing combo. 3x annually |
| Larazotide (AT-1001) | 5mg | 0.5-1mg | 1-2x/day before meals | Oral (submucosal) | Tight junction regulator. Celiac disease, leaky gut, intestinal permeability. Swish and hold 60-90 sec. 6-8 week cycles. Synergistic with BPC-157 and KPV |
| LL-37 (Cathelicidin) | 5mg | 100-500mcg | 3x/week | SubQ/IM | Antimicrobial host-defense peptide. Chronic sinusitis, wound healing, immune optimization. Also topical 0.1-1% and intranasal |
| BPC-157 / GHK-Cu / L-Carnosine Oral Blend | Oral Cap | 1 capsule | Daily AM (5 on / 2 off) | Oral | Multi-phase enteric micro-pellet. Take on empty stomach. Post-procedure, orthopedic, aesthetic recovery. Avoid co-admin with anticoagulants without physician approval |
Recovery
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| ARA-290 | 10mg | 1.6-4mg | 5-7 days/week x 30 days | SubQ | Reconstitute with pH 7.4 PBS - NOT bacteriostatic water. Requires PBS for molecular stability. Higher doses studied for chronic pain and inflammation |
| Cartalax | 20mg | 2-5mg | 5-7 days/week x 10-20 days | SubQ/IM | Cartilage and connective tissue regeneration. DO NOT use if pregnant/breastfeeding |
Hair, Skin & Collagen
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| AHK-Cu | 5mg | 200-500mcg | 5 days on / 2 off | SubQ | Copper peptide. Wound healing, hair growth, skin rejuvenation. Enhanced tissue targeting vs. GHK-Cu |
| GLOW Blend (GHK-Cu / BPC-157 / TB-500) | 70mg | 3.5-7mg | Daily x 20 days | SubQ | Skin, longevity, healing combo. 3x annually |
| GHK-Cu | 50mg | 1-2mg | Daily, 30 days on / 14 days off | SubQ | Wound healing, anti-aging. Can add to topical carrier for serum use. Synergistic with SNAP-8 and BPC-157 |
| GHK-Cu | 100mg | 1-2mg | Daily, 30 days on / 14 days off | SubQ | 30 days on / 14 days off. Wound healing, anti-aging |
| SNAP-8 (Acetyl Octapeptide-3) | 10mg | Apply to affected areas | BID (AM + PM) | Topical | Botox-like topical. Expression wrinkle reduction. Combine with GHK-Cu for best results |
| SNAP-8 + GHK-Cu Topical Serum | 30mL | 2-4 drops | BID (AM + PM) | Topical | Dual-mechanism cosmetic serum. SNAP-8 inhibits SNARE complex; GHK-Cu drives collagen synthesis. Apply to cleansed face/neck. Maintenance between injectable cycles |
Weight Management
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| KLOW Blend | 80mg (50/10/10/10) | 4-8mg | Daily | SubQ | Comprehensive weight loss and skin blend |
| AOD-9604 | 5mg | 500mcg-1mg | 5 days on / 2 off | SubQ | Fasted before bed or upon waking. Can split AM/PM doses |
| AOD-9604 | 10mg | 500mcg-1mg | 5 days on / 2 off | SubQ | Fasted before bed or upon waking. Can split AM/PM doses |
| Orforglipron | Oral Cap | 3-45mg | 1x/day | Oral | Non-peptide oral GLP-1 receptor agonist. Titrate: 3mg to 6mg to 12mg to maintenance 24-45mg (x14 days each). Empty stomach, 30 min before food |
| Cagrilintide | 10mg | 300mcg-4.5mg | 1x/week | SubQ | Can be added to GLP-1 to reduce that dosage |
| Semaglutide (GLP-1) | 5mg | 250mcg-2.5mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 250mcg |
| Semaglutide (GLP-1) | 10mg | 250mcg-2.5mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 250mcg |
| Semaglutide (GLP-1) | 30mg | 250mcg-2.5mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 250mcg |
| Tirzepatide (GLP-1/GIP) | 5mg | 2.5-15mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 2.5mg |
| Tirzepatide (GLP-1/GIP) | 10mg | 2.5-15mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 2.5mg |
| Tirzepatide (GLP-1/GIP) | 15mg | 2.5-15mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 2.5mg |
| Tirzepatide (GLP-1/GIP) | 30mg | 2.5-15mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 2.5mg |
| Tirzepatide (GLP-1/GIP) | 60mg | 2.5-15mg (titrate) | 1x/week | SubQ | Same day every week. Starting dose 2.5mg |
| Retatrutide (GLP-1/GIP/Glucagon) | 5mg | 2-12mg (titrate) | 1x/week | SubQ | Triple receptor agonist. Starting dose 2mg. Less brain fog, more energy |
| Retatrutide (GLP-1/GIP/Glucagon) | 10mg | 2-12mg (titrate) | 1x/week | SubQ | Triple receptor agonist. Starting dose 2mg. Less brain fog, more energy |
| Retatrutide (GLP-1/GIP/Glucagon) | 30mg | 2-12mg (titrate) | 1x/week | SubQ | Triple receptor agonist. Starting dose 2mg |
| Retatrutide (GLP-1/GIP/Glucagon) | 60mg | 2-12mg (titrate) | 1x/week | SubQ | Triple receptor agonist. Starting dose 2mg |
| Survodutide | 10mg | 600mcg-4.5mg (titrate) | 1x/week | SubQ | Dual GLP-1/Glucagon agonist. Starting dose 600mcg. Helps fatty liver |
| Mazdutide | 10mg | 1.5-6mg (titrate) | 1x/week | SubQ | Dual GLP-1/Glucagon agonist. Start 1.5mg, titrate to 6mg maintenance |
| 5-Amino-1MQ | 5mg | 5-10mg | 1-3x/week | SubQ | NNMT inhibitor. Metabolic activator. 2-4 week cycles for resistant fat patterns |
| 5-Amino-1MQ | 10mg | 5-10mg | 1-3x/week | SubQ | NNMT inhibitor. Metabolic activator. 2-4 week cycles for resistant fat patterns |
| Adipotide (FTPP) | 5mg | 0.5-5mg | Daily x 4 weeks | SubQ | INVESTIGATIONAL. Requires intensive kidney monitoring. Max 5mg/day |
| HGH Fragment 176-191 | 5mg | 250-500mcg | BID (morning fasted + pre-bed) | SubQ | Fat loss fragment. 4-12 weeks. No IGF-1 or diabetogenic effects |
| SLU-PP-332 | 5mg | 2-5mg | Daily (5 on / 2 off) | SubQ | UCP1 inducer. Thermogenic compound. 8-12 week cycles |
| LC120 (Lipo-C Metabolic Blend) | 10mL | 1mL | 1-2x/week | IM/SubQ | Methionine 15mg, Choline 50mg, L-Carnitine 50mg, B5 5mg. Lipotropic support |
| LC216 (Advanced Metabolic Blend) | 10mL | 1mL | 1-2x/week | IM/SubQ | L-Carnitine, Arginine, Methionine, Inositol, Choline, B vitamins. Enhanced lipotropic |
| L-Carnitine (LC-600) | 10mL | 200-500mg | 1-3x/week | IM | High-dose injectable L-Carnitine. Fat oxidation, energy, performance |
| mcIRBP-19 (Bitter Melon Peptide) | 5mg | 500mcg-1mg | Daily (5 on / 2 off) | SubQ | Plant-derived insulin receptor-binding peptide (FDA NDI-accepted). Post-prandial glucose regulation. Inject before largest meal. Pairs with MOTS-c |
| mcIRBP-19 (Bitter Melon Peptide) Oral | Oral Cap | 500mcg-1mg | Daily with or before meals | Oral | FDA NDI-accepted bitter melon insulin-binding peptide. Glucose regulation support. Take before largest meal. Synergistic with MOTS-c, Berberine, Chromium |
| Orforglipron / ALCAR / L-Carnitine L-Tartrate Oral | Oral Cap 1 Blend | capsule | Daily AM (5 on / 2 off) | Oral | Fixed 6mg oral GLP-1 agonist + dual carnitine. Empty stomach 30-45 min before food. Oral option for injection-averse patients. HPMCAS enteric capsule |
| MOTS-c / mcIRBP-19 / Botanical Metabolic Oral Blend | Oral Cap | 1 capsule | Daily AM (5 on / 2 off) | Oral | Multi-pathway natural GLP-1 support, thermogenesis, AMPK activation, lean mass preservation (HMB). Adjunct to GLP-1 prescriptions or standalone metabolic support |
Anti-Viral & Anti-Microbial
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| KPV | 5mg | 250-500mcg | Based on injury/illness | SubQ | After surgery, preventative, or during illness. IBD support |
| KPV | 10mg | 250-500mcg | Based on injury/illness | SubQ | After surgery, preventative, or during illness. IBD support |
Growth Hormone Releasing
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| CJC-1295 (No DAC) | 5mg | 200mcg-1mg | 5 days on / 2 off | SubQ | Fasted - 45 minutes before and after injection |
| CJC-1295 (No DAC) | 10mg | 200mcg-1mg | 5 days on / 2 off | SubQ | Fasted - 45 minutes before and after injection |
| CJC-1295 (with DAC) | 5mg | 1-2mg | 1-2x/week | SubQ | Longer half-life than No DAC version. Extended GH release |
| CJC-1295 (No DAC) / Ipamorelin Blend | 5mg/5mg | 500mcg-1mg | 5 days on / 2 off | SubQ | Fasted administration. Bedtime or AM dosing |
| GHRP-2 | 5mg | 200mcg-1mg | 5 days/week up to 8 weeks | SubQ | Empty stomach 30 min before meals. May increase appetite |
| GHRP-2 | 10mg | 200mcg-1mg | 5 days/week up to 8 weeks | SubQ | Empty stomach 30 min before meals. May increase appetite |
| GHRP-6 | 5mg | 150-300mcg | As needed before meals | SubQ | Multiple times daily before meals. Increases appetite |
| GHRP-6 | 10mg | 150-300mcg | As needed before meals | SubQ | Multiple times daily before meals. Increases appetite |
| Hexarelin | 5mg | 100mcg (3x daily) | 3x daily for 20 weeks | SubQ | Most potent GHRP. No appetite/cortisol increase |
| Ipamorelin | 5mg | 200-300mcg | 5 days on / 2 off | SubQ | Fasted 30 min before each meal, up to 3x daily. No appetite increase |
| Ipamorelin | 10mg | 200-300mcg | 5 days on / 2 off | SubQ | Fasted 30 min before each meal, up to 3x daily. No appetite increase |
| Sermorelin | 5mg | 500mcg-2mg | 5 days on / 2 off | SubQ | Fasted 2 hrs before first meal or before bed |
| Sermorelin | 10mg | 500mcg-2mg | 5 days on / 2 off | SubQ | Fasted 2 hrs before first meal or before bed |
| Tesamorelin | 5mg | 1-2mg | 5 days on / 2 off | SubQ | Before bedtime. Decreases visceral fat |
| Tesamorelin | 10mg | 1-2mg | 5 days on / 2 off BRAIN + MOOD | SubQ | Before bedtime. Decreases visceral fat |
| Adamax (N-Acetyl Semax Analog) | 10mg | 100-500mcg | Daily or EOD | Intranasal/SubQ Intranasal | preferred: 100mcg/nostril 1-2x daily. SC: 100-200mcg daily. Cycle 5/2 or 10/4. Synergistic with Selank, Pinealon, Dihexa, SS-31, NAD+ |
| Cerebrolysin | 60mg | 60-120mg | Daily or EOD x 10-20 days | IM | Neurotrophic peptide complex. 2-4 cycles/year. Cognitive support. Reconstitute with bacteriostatic water |
| Dihexa | 5mg | 1-3mg | Daily (morning) | SubQ | HGF/c-Met modulator. Cognitive enhancement. Start low, titrate slowly |
| Dihexa | 10mg | 1-5mg | Daily (morning) | SubQ | HGF/c-Met modulator. Cognitive enhancement. Avoid evening dosing |
| NAD+ | 100mg | 50-100mg | Daily or 2x/week | IM | Single dose not to exceed 250mg |
| NAD+ | 500mg | 50-150mg | Daily or 2x/week | IM | Single dose not to exceed 250mg |
| NAD+ | 1,000mg | 100-250mg | Daily or 2x/week | IM/IV | High-volume vial for IV drip protocols - dilute in NS/D5W. IM single dose not to exceed 250mg. IV: 500-1,000mg over 2-4 hrs |
| Oxytocin | 2mg | 100-400mcg | Daily | SubQ | Love hormone. Social bonding, stress/anxiety relief |
| Oxytocin | 5mg | 250-500mcg | Daily | SubQ | Love hormone. Social bonding, stress/anxiety relief |
| Oxytocin | 10mg | 250-500mcg | Daily | SubQ | Love hormone. Social bonding, stress/anxiety relief |
| PE-22-28 (Spadin Analog) | 10mg | 50-200mcg | Daily (5 on / 2 off) | SubQ | TREK-1 channel blocker, antidepressant mechanism. Start 50mcg/day; titrate to 100-200mcg; ceiling 600mcg for refractory cases. Morning dosing. Synergistic with Selank, Semax, Dihexa |
| Pinealon | 10mg | 100-300mcg | Daily x 10-20 days | SubQ | Neuroprotective tripeptide. Cognitive, anti-aging. Maintenance: 100-200mcg 2-3x/week |
| Pinealon | 20mg | 300-500mcg | Daily x 10-20 days | SubQ | Neuroprotective tripeptide. Higher dose for injury recovery |
| Selank | 5mg | 250-500mcg | Daily | SubQ | Anti-anxiety. Serotonin/dopamine signaling. Enhanced learning |
| Selank | 10mg | 250-500mcg | Daily | SubQ | Anti-anxiety. Serotonin/dopamine signaling. Enhanced learning |
| Semax | 5mg | 500mcg-1mg | Daily | SubQ | BDNF release. Neuroplasticity, blood flow to brain |
| Semax | 10mg | 500mcg-1mg | Daily | SubQ | BDNF release. Neuroplasticity, blood flow to brain |
| Anserine (Oral) | Oral Cap | 250-500mg | Daily | Oral | Neuroprotective anti-glycation dipeptide. Cognitive and physical function support. DSHEA dietary ingredient. Synergistic with Mg L-Threonate and Glutathione |
| L-Theanine (Oral) | Oral Cap | 100-400mg | Daily or as needed | Oral | FDA GRAS tea amino acid. Calm-focus without sedation. AM for focus or PM for sleep/stress. Synergistic with NAD+, Semax, Selank |
| Magnesium L-Threonate (Oral) | Oral Cap | 500-1,500mg | Daily (PM preferred) | Oral | Brain-penetrating magnesium form (Magtein). Elevates CSF Mg2+ and improves memory parameters. FDA GRAS self-affirmed |
| Brain Health Neuro-Support Blend Oral | Oral Cap | 2 capsules | Nightly before bed (5 on / off) | 2 Oral Stage-release: Immediate - Anserine + L-Theanine; Mid-phase - Mg L-Threonate; Enteric - Glutathione; Delayed - Cerluten A-5. Cognitive decline, oxidative stress, neuroinflammation |
Delta Sleep
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| DSIP | 5mg | 500mcg-1mg | As needed before bed | SubQ | Delta Sleep Inducing Peptide. Circadian clock reset, withdrawal support |
| DSIP | 15mg | 500mcg-1mg | As needed before bed | SubQ | Delta Sleep Inducing Peptide. Circadian clock reset, withdrawal support |
Longevity
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| Cerluten A-5 (Oral) | Oral Cap | 2-5mg | Daily, 10-20 day cycles | Oral | Bovine CNS-derived peptide bioregulator. Neuroprotection, circadian regulation. Glandular supplement (DSHEA). 2-3 cycles annually. Synergistic with Pinealon and Epitalon |
| Epithalon | 10mg | 10mg | 20 bottle cycle (daily x 20 days) | SubQ | 2-3x annually. Telomere lengthening, melatonin support |
| Epithalon | 50mg | 10-20mg | 4 bottle cycle over 10-20 days | SubQ | 3x annually. Telomere lengthening |
| FOXO4-DRI | 10mg | 5mg | 2-3 days per cycle, every 1-3 months | SubQ | Senolytic peptide. Clears senescent cells. Not for continuous use |
Melanin & Skin
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| Melanotan-1 (Afamelanotide) | 10mg | 250-500mcg | Daily or EOD (loading), Weekly (maintenance) | SubQ | Photoprotection and tanning. Safer profile than MT-II |
Immunity
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| LL-37 | 5mg | 300mcg-1mg | During illness | SubQ | Stop use when feeling healthy. Natural antibiotic |
| Thymosin Alpha-1 (TA-1) | 5mg | 1.5-4mg | When sick 2x/week | IM | 4x/year for immune support. Stimulates T-cells, dendritic cells |
| Thymosin Alpha-1 (TA-1) | 10mg | 3-8mg | When sick 2x/week | IM | 4x/year for immune support. Stimulates T-cells, dendritic cells |
| Thymalin | 10mg | 5-10mg | Daily x 10 days | SubQ/IM | 2-3x/year. Thymus gland support |
| Thymalin | 20mg | 5-10mg | Daily x 10 days | SubQ/IM | 2-3x/year. Thymus gland support |
Immunity & Neuroimmune
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| VIP (Vasoactive Intestinal Peptide) | 5mg | 50-100mcg | 1-4x daily | Intranasal/SubQ | CIRS, dysautonomia, pulmonary support. Start low, titrate. SC: 50-200mcg |
| VIP (Vasoactive Intestinal Peptide) | 10mg | 50-200mcg | 1-4x daily | Intranasal/SubQ | CIRS, pulmonary support. SC option: 100mcg 3x weekly |
Libido & ED
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| PT-141 (Bremelanotide) | 5mg | 500mcg-1mg | 2 hrs before activity PRN | SubQ | Not to exceed 20 units. Consult doctor |
| PT-141 (Bremelanotide) | 10mg | 500mcg-1mg | 2 hrs before activity PRN | SubQ | Not to exceed 20 units. Consult doctor |
Melanin & Libido
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| Melanotan II (MT-II) | 10mg | 500mcg-1mg | Before tanning | SubQ | Use 30 minutes before tanning |
Reproductive Health
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| Kisspeptin | 5mg | 100-200mcg | When needed | SubQ | Hormone balance, reproductive health, wellness |
| Kisspeptin | 10mg | 100-200mcg | When needed | SubQ | Hormone balance, reproductive health, wellness |
Mitochondrial Function
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| AICAR | 50mg | 5-10mg | 5-10 days per cycle | SubQ | AMPK activator. Exercise mimetic. 2-4 cycles/year |
| Humanin | 5mg | 5-20mg | 3x/week or QOD | SubQ | Mitochondrial-derived peptide. Neuroprotective. 4-6 week cycles |
| Humanin | 10mg | 5-20mg | 3x/week or QOD | SubQ | Mitochondrial-derived peptide. Neuroprotective. 4-6 week cycles |
| MOTS-c | 10mg | 5-10mg | Every 5 days x 20 days | SubQ | 3x annually. T2 diabetic: 1mg EOD to lower blood sugars |
| MOTS-c | 40mg | 5-10mg | Every 5 days x 20 days | SubQ | 3x annually. Exercise mimetic, insulin sensitization |
| SS-31 (Elamipretide) | 10mg | 5mg | Daily x 22 days (11 bottle cycle) | SubQ | 3x/year. Best before MOTS-c cycle. Targets inner mitochondrial membrane |
| 5-Amino-1MQ / SLU-PP-332 / NAD+ Oral Blend | Oral Cap | 1 capsule | Daily AM (5 on / 2 off) | Oral | Mitochondrial activation stack: Immediate - NAD+; Sustained - SLU-PP-332 (ERR-alpha/gamma); Delayed - 5-Amino-1MQ (NNMT inhibition). Take on empty stomach |
Antioxidant & Detox
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| Glutathione | 1500mg | 200-600mg (IM) / 1000-2000mg (IV) | 2-4x/week | IM/IV | Master antioxidant. Detoxification, skin brightening, post-NAD+ support |
| Carnosine (L-Carnosine) Oral | Oral Cap | 500-1,000mg | Daily | Oral | Anti-glycation dipeptide. Neutralizes reactive carbonyl species, preserves redox stability. Supports cellular longevity and post-exercise recovery |
Muscle Development
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| Follistatin 344 | 1mg | 200mcg | 4 bottle cycle over 20 days | IM | 3x annually. Myostatin inhibitor |
| MGF (IGF-1EC) | 2mg | 200-400mcg | Post workout | IM | Mechano Growth Factor. Inject into trained muscle |
| MGF (IGF-1EC) | 5mg | 200-400mcg | Post workout | IM | Mechano Growth Factor. Inject into trained muscle |
Growth Factor
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| IGF-1 LR3 | 0.1mg | 20-50mcg | 5 days on / 2 off | IM | After meal / before gym. Lower dose option |
| IGF-1 LR3 | 1mg | 100-200mcg | 5 days on / 2 off | IM | After meal / before gym |
Performance & Recovery
| Peptide | Vial | Reported range | Frequency | Route | Notes & cautions |
|---|---|---|---|---|---|
| Super Human Blend (SHB) | 10mL | 1mL | Daily or pre-exercise | IM/SubQ | Multi-amino acid blend: Arginine/Citrulline (NO), Ornithine (urea cycle), L-Carnitine, Lysine/Proline/Glutamine, NAC/Taurine. Pre-exercise 30-60 min before training |
Reported, not recommended — not medical advice. Research use only; not for human or animal consumption. Compiled 2026-09-29 from peptideprotocolportal.com. Printed from resinstitute dosing reference — check the site for the current version.